
PDS Biotechnology Corporation
PDSBHealthcare|Biotechnology|US
$1.23
+0.06 (+5.13%)
DCF Value
$0.14
Cash / Share
$0.10
Next Earnings Report
Nov 12, 2026
EPS est. -$0.09
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Oct 14, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
Oct 20, 2026 · GlobeNewsWire
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
Oct 6, 2026 · GlobeNewsWire
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology
Sep 22, 2026 · GlobeNewsWire
PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors
Sep 14, 2026 · GlobeNewsWire
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
Sep 8, 2026 · GlobeNewsWire
PDS Biotech Reports Second Quarter 2026 Financial Results
Aug 13, 2026 · GlobeNewsWire
SEC Filings (89)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 21, 2026 | 8-K | Material event | DocumentIndex |
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Oct 14, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Sep 22, 2026 | 8-K | Material event | DocumentIndex |
| Sep 21, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Sep 21, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Sep 8, 2026 | 8-K | Material event | DocumentIndex |
| Sep 4, 2026 | 8-K | Material event | DocumentIndex |
| Aug 25, 2026 | 8-K | Material event | DocumentIndex |
| Aug 19, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 11, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 21, 2026 | EFFECT | DocumentIndex | |
| Jul 21, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Jul 10, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jun 26, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jun 26, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 26, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 15, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jun 15, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 15, 2026 | 8-K | Material event | DocumentIndex |
| Jun 15, 2026 | 8-K | Material event | DocumentIndex |
| Jun 2, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 1, 2026 | 8-K | Material event | DocumentIndex |
| Apr 28, 2026 | EFFECT | DocumentIndex | |
| Apr 28, 2026 | 10-K/A | Annual report | DocumentIndex |
| Apr 24, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Apr 24, 2026 | 8-K | Material event | DocumentIndex |
| Apr 15, 2026 | 8-K | Material event | DocumentIndex |
| Mar 30, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 30, 2026 | 8-K | Material event | DocumentIndex |
| Mar 3, 2026 | 8-K | Material event | DocumentIndex |
| Feb 23, 2026 | 8-K | Material event | DocumentIndex |